Revance Therapeutics reported $19.74M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14342M 383M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Aerie Pharmaceuticals AERI:US $ 29.31M 2.13M
ALKERMES ALKS:US $ 294.14M 9.58M
Biodelivery Sciences International BDSI:US $ 41.09M 0.35M
Bristol Myers Squibb BMY:US $ 11624M 79M
Cara Therapeutics CARA:US $ 20.27M 20.27M
Coherus Biosciences CHRS:US $ 82.5M 5.14M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Endo International Ordinary Shares ENDP:US $ 772.03M 58.2M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Horizon Pharma HZNP:US $ 1036.99M 204.44M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Johnson & Johnson JNJ:US $ 23338M 26M
Merk MRK:US $ 13154M 1752M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Procter & Gamble PG:US $ 20338M 1392M
Revance Therapeutics RVNC:US $ 19.74M 0.94M
Supernus Pharmaceuticals SUPN:US $ 148.46M 7.14M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M
Zogenix ZGNX:US $ 22.61M 3.82M